Advanced Infusion Therapies Delivered with Safety, Expertise, and Care.

Entyvio® (Vedolizumab) IV Infusion Therapy in Miami

Gut-Targeted Biologic Therapy for Crohn’s Disease and Ulcerative Colitis

Looking for Entyvio infusion therapy near you? Clearwell Infusion Centers offers safe, expert administration of Entyvio (vedolizumab) for patients with moderate to severe inflammatory bowel disease (IBD). As a leading infusion center in Miami, we provide private suites, flexible scheduling, and personalized, patient-centered care.

What Is Entyvio?

Entyvio® (vedolizumab) is an FDA-approved biologic therapy used to treat adults with moderate to severe ulcerative colitis or Crohn’s disease. It is a monoclonal antibody that specifically targets the gut’s immune system by blocking the α4β7 integrin, which plays a key role in chronic gastrointestinal inflammation.

Entyvio is administered by intravenous (IV) infusion, typically every 8 weeks after the initial loading doses.

Conditions Treated with Entyvio

Entyvio is indicated for adult patients with:

  • Moderate to severe Ulcerative Colitis (UC)
  • Moderate to severe Crohn’s Disease (CD)

Entyvio is generally prescribed when conventional treatments, such as corticosteroids or immunomodulators, have not provided sufficient symptom relief or remission.

Entyvio Side Effects

Entyvio is generally well tolerated, but as with all biologic therapies, side effects may occur.

Common side effects:

  • Headache
  • Nausea
  • Joint pain
  • Fatigue
  • Fever
  • Upper respiratory infections
  • Infusion-related reactions (chills, rash, itching)

Serious infections are rare but possible. Patients are monitored during and after infusion for any adverse reactions.

For a full list of potential side effects, please see the Important Safety Information and Medication Guide on the Entyvio Website.

Why Choose Clearwell for Your Entyvio Infusion?

At Clearwell Infusion Centers in Miami, we provide a comfortable, efficient environment for Entyvio therapy. When you receive Entyvio IV treatment at Clearwell, you benefit from:

  • Private treatment suites with spa-like amenities
  • Low patient-to-nurse ratio for attentive care
  • Flexible appointment times, including weekends and evenings
  • Comprehensive insurance coordination, including prior authorizations and benefits checks
  • ACHC-accredited facility and safety standards
  • Close coordination with your prescribing provider and care team

Entyvio infusions typically take about 30 minutes and are administered every 8 weeks following the initial 0, 2, and 6-week induction doses.

Getting Started with Entyvio Treatment

If you’ve been diagnosed with Crohn’s disease or ulcerative colitis and prescribed Entyvio, Clearwell can help you get started quickly and confidently. We’ll coordinate with your gastroenterologist, confirm insurance coverage, and ensure your treatment experience is smooth and stress-free.

Questions? Call us at 305‑306‑7147 or email contact@clearwellinfusion.com.

Referring Providers: Partner with Clearwell Infusion Centers

Clearwell Infusion Centers works closely with gastroenterologists and IBD specialists to deliver safe, protocol-driven Entyvio therapy in an outpatient setting.

Why refer your patients to Clearwell?

  • Fast turnaround for benefit verifications and prior authorizations
  • Easy referral process and same-week scheduling
  • Clinical documentation and follow-up sent to your office
  • FDA-approved Cinryze administered by experienced infusion nurses
  • ACHC-accredited and compliant with all safety protocols

To refer a patient for Entyvio therapy in Miami, contact our provider team at referrals@clearwellinfusion.com or call 305‑306‑7147.

Logo of Entyvio® (vedolizumab), a biologic therapy for ulcerative colitis and Crohn's disease.

Looking to start your Entyvio treatment at Clearwell Infusion Centers?

Fill out the form below and a member of our team will contact you

← Back

Your message has been sent and a member of our team will contact you. You can call us at (305)306-7147